JOURNAL OF NANOBIOTECHNOLOGY is a distinguished academic journal published by BMC in the field of nanobiotechnology, focusing on the intersection of nanoscience, biotechnology, and biomedical engineering. Since its inception in 2003, this open-access journal has played a pivotal role in disseminating high-quality research, becoming a leading platform for innovators and scholars alike. With a remarkable impact factor and consistently ranking in the Q1 category across multiple fields—including Applied Microbiology, Bioengineering, and Pharmaceutical Science—the journal demonstrates its critical relevance and influence in advancing knowledge and applications in nanobiotechnology. Furthermore, its impressive Scopus rankings reflect its commitment to rigorously peer-reviewed content, making it a go-to resource for researchers, professionals, and students striving to push the boundaries of science. Given its broad scope, covering emerging trends and technologies, JOURNAL OF NANOBIOTECHNOLOGY continues to foster collaboration and innovation across multidisciplinary fields, inviting submissions from across the globe.

International Journal of Nanomedicine, published by DOVE MEDICAL PRESS LTD, is a leading open access journal dedicated to advancing the field of nanomedicine and its applications in healthcare. Since its establishment in 2006, the journal has grown significantly, now encompassing a wide array of topics including bioengineering, biomaterials, biophysics, drug discovery, and pharmaceutical sciences, and is recognized in Q1 quartiles across major categories like *Nanoscience and Nanotechnology* and *Organic Chemistry*. The journal boasts an impressive standing within the Scopus rankings, with high percentiles across various related fields, making it an invaluable resource for researchers, professionals, and students seeking to stay informed on the latest innovations and developments in nanomedicine. With its commitment to fostering an accessible and collaborative academic environment, the International Journal of Nanomedicine serves as a vital platform for disseminating transformative research that impacts scientific practice and healthcare outcomes globally.

ACS Applied Bio Materials is a leading academic journal published by the American Chemical Society, focusing on the innovative intersection of bioengineering and materials science. Since its inception in 2018, the journal has established itself as a pivotal platform for disseminating impactful research within the fields of Biochemistry, Biomaterials, Biomedical Engineering, and Chemistry, often ranked in the top tiers of these categories. With an impressive impact factor, it holds a Q2 ranking in both Biochemistry and Biomaterials, and a prestigious Q1 ranking in Biomedical Engineering and miscellaneous Chemistry, underscoring its significance in advancing knowledge and practices across these disciplines. The journal’s editorial commitment to high-quality, peer-reviewed research ensures relevance and rigor, appealing to a diverse audience of researchers, professionals, and students keen to explore breakthroughs in bio-related materials technology. The access options enhance its visibility and reach, allowing for a broader dissemination of studies that drive innovation and collaboration in biotechnology and material sciences. Located in the heart of Washington, DC, ACS Applied Bio Materials serves as a crucial resource for advancing the future of healthcare, engineering, and materials research.

Frontiers in Materials, an esteemed journal published by FRONTIERS MEDIA SA, is a leading platform in the field of Materials Science, with a notable impact factor placing it in the Q2 category of its discipline as of 2023. Since its establishment as an Open Access journal in 2014, it has fostered considerable academic exchange, allowing researchers from around the globe to share their innovative findings and insights. Based in Lausanne, Switzerland, this journal not only emphasizes high-quality peer-reviewed articles but also prioritizes rapid dissemination of research, as evidenced by its commendable Scopus ranking of #62 out of 196 in Materials Science (miscellaneous). By consistently striving to bridge the gap between academia and practical applications, Frontiers in Materials serves as an invaluable resource for researchers, professionals, and students seeking to delve into cutting-edge advancements and transformative applications in materials science.

Bioactive Materials, published by KEAI PUBLISHING LTD, stands as a leading Open Access journal in the fields of Biomaterials, Biomedical Engineering, and Biotechnology. Since its inception in 2016, this journal has rapidly ascended in prominence, currently holding a prestigious Q1 category ranking across multiple disciplines, reflecting its significant impact within the scientific community. With its E-ISSN 2452-199X, it spans a broad spectrum of research areas, contributing valuable insights to the ongoing discourse in bioactive materials and their applications. The journal's superior Scopus rankings further illustrate its influence, boasting impressive standings in engaging niches such as engineering and molecular biology. Bioactive Materials offers a vital platform for researchers, professionals, and students to disseminate and acquire cutting-edge knowledge, thus fostering innovation and collaboration in the rapidly evolving terrain of biomedicine. Its commitment to Open Access since 2016 enhances accessibility, ensuring that the burgeoning advancements in this field reach a global audience.

Functional Materials is a pioneering journal dedicated to the exploration and application of innovative materials science. Published by the NATL ACAD SCIENCES UKRAINE, INST SINGLE CRYSTALS, this journal provides a platform for researchers, professionals, and students to disseminate their findings in the realm of functional materials, which play a crucial role in various technological advancements. With an ISSN of 1027-5495 and E-ISSN 2218-2993, Functional Materials features research articles that span the spectrum of material properties and behaviors, contributing to both theoretical and applied sciences. Despite its current categorization in the Q4 quartile of Materials Science (miscellaneous) as of 2023, the journal aspires to foster impactful research, encouraging submissions that push the boundaries of knowledge and innovation in the field. Located in Kharkiv, Ukraine, the journal is an integral resource for anyone involved in materials science, providing insights that drive future discoveries and applications.

Biofabrication, published by IOP Publishing Ltd, stands at the forefront of the interdisciplinary fields of biochemistry, bioengineering, biomaterials, biomedical engineering, biotechnology, and miscellaneous medicine. Since its inception in 2009, this prestigious journal has secured its position within the Q1 category across multiple disciplines as of 2023, reflecting its high impact and significant contribution to advancing research in these domains. With ranks such as #19 in biochemistry and #10 in biomaterials according to Scopus, it showcases groundbreaking studies and innovative methodologies that are crucial for the evolution of biofabrication technologies. Authored by leading researchers and professionals, the journal publishes articles that explore the synthesis, characterization, and application of biomaterials, providing valuable insights for both academic researchers and industry practitioners. The impact factor of the journal, combined with its rigorous peer-review process, guarantees high-quality content that pushes the boundaries of knowledge and technology. Researchers and students engaged in these dynamic fields will find Biofabrication an indispensable resource for staying abreast of critical developments and emerging trends.

ACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.

BIOPOLYMERS, a distinguished journal founded in 1963 and published by WILEY, serves as an essential platform for the dissemination of research in the fields of biochemistry, biomaterials, biophysics, and organic chemistry. With an ISSN of 0006-3525 and E-ISSN 1097-0282, this journal has been pivotal in advancing our understanding of the intricate roles that biopolymers play in various biological systems and their applications in medicine and technology. The journal is recognized for its rigorous peer-review process and has established itself within the academic community, boasting impressive Scopus rankings across multiple disciplines, including a Q2 ranking in both Biophysics and Medicine for 2023. Although it does not offer Open Access options, BIOPOLYMERS provides invaluable access to critical insights and developments in the study of biopolymers, appealing to researchers, professionals, and students dedicated to innovating in this dynamic field.

The Journal of Biomimetics Biomaterials and Biomedical Engineering, published by TRANS TECH PUBLICATIONS LTD, stands at the forefront of interdisciplinary research that merges biology with engineering to address real-world challenges in healthcare and material science. Since its inception in 2014, the journal has contributed valuable insights into the development of innovative biomaterials and biomedical applications, showcasing research excellence in its fields, including biotechnology and bioengineering. With an ISSN of 2296-9837 and an E-ISSN of 2296-9845, this journal provides a platform for both emerging and established researchers to disseminate their work, fostering knowledge transfer across the global scientific community. Currently positioned in the Q4 quartile across categories such as Bioengineering, Biomedical Engineering, and Biotechnology, it aims to enhance its impact through open-access policies and rigorous peer-review processes. With its headquarters in Germany, the journal welcomes diverse contributions from around the world, shaping the future of biomimetic technologies and advancing our understanding of complex biomedical systems.